ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,428, issued on Dec. 23, was assigned to Utopia Therapeutics Pvt Ltd. (Telangana, India).

"Immunotherapeutic composition for prevention of obesity, nonalcoholic fatty liver disease and hypertriglyceridemia, and methods of use and preparation thereof" was invented by Uday Saxena (Hyderabad, India) and Gopi Kadiyala (Karnataka, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides a vaccine including a peptide with the amino acid sequence of SEQ ID NO:1; a nucleotide having the sequence of SEQ ID NO:2; or a ribonucleotide having the sequence of SEQ ID NO:3. In certain embodiments, the vaccine further comprises a buffer and/or an...